This article is more than 5 years old. Information may no longer be current.
Fluoroquinolone safety risks, Apple Watch studies and more — the week’s top stories in cardiology
Top stories in cardiology last week included a study that found an association between fluoroquinolones and increased risks for aortic and mitral regurgitation, and the announcement that new Apple Watch studies will focus on cardiovascular health, women’s health, and hearing.
A study that found gut microbiome indicators could lead to better prevention, diagnosis and treatment of hypertension in patients with or without depression was another top story.
Fluoroquinolones pose risk for aortic, mitral regurgitation
Current and recent use of fluoroquinolones, but not past use, were associated with elevated risk for aortic and mitral regurgitation, researchers reported. Read more.
New Apple Watch studies to explore CV, women’s health
Apple announced that it is launching three studies leveraging the Apple Watch’s capabilities to allow people to track their heart rate and movement, to allow women to track their menstrual cycles and to determine how routine sound exposure affects hearing. Read more.
Indicators in gut microbiome may lead to better diagnosis, treatment of high BP
Analyzing bacteria in the gut, researchers have determined that patients presenting with hypertension plus depression may have an entirely different disease than those with hypertension alone, according to preliminary research presented at the American Heart Association’s 2019 Hypertension Scientific Sessions. Read more.
Treatment for high BP may slow cognitive decline in older patients
The treatment of high BP may slow down the advancement of cognitive decline, according to research presented at the American Heart Association’s Hypertension Scientific Sessions. Read more.
Medical school students at greater risk for hypertension than general public
Factors including sex, waist size and sleep contribute to medical students having an approximately 2.4 times higher prevalence of hypertension than the general population, according to research presented at the American Heart Association Hypertension Scientific Sessions. Read more.